safer < safety < saharan

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 80.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000004 (1990)	Susan Tett ; David Cutler ; Richard Day	Antimalarials in rheumatic diseases
000007 (2006)	A. Wozniacka [Pologne] ; I. Cygankiewicz [Pologne] ; M. Chudzik [Pologne] ; A. Sysa-J Drzejowska ; Jk Wranicz [Pologne]	The Cardiac Safety of Chloroquine Phosphate Treatment in Patients with Systemic Lupus Erythematosus: The Influence on Arrhythmia, Heart Rate Variability and Repolarization Parameters
000032 (2015)	Sarah Braun [Allemagne] ; Marion Ferner [Allemagne] ; Kai Kronfeld [Allemagne] ; Matthias Griese [Allemagne]	Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases
000034 (1988)	Robert I. Fox [États-Unis] ; Edward Chan [États-Unis] ; Laurie Benton [États-Unis] ; Sherman Fong [États-Unis] ; Mitchell Friedlaender [États-Unis] ; Francis V. Howell [États-Unis]	Treatment of primary Sjögren's syndrome with hydroxychloroquine
000240 (2012)	A. Klein [Allemagne] ; B. Coras [Allemagne] ; M. Landthaler [Allemagne] ; P. Babilas [Allemagne]	Off‐label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study
000280 (1990)	Jill P. Buyon	Systemic lupus erythematosus and the maternal-fetal dyad
000295 (2002)	K. Pavelka [République tchèque] ; Š. Forejtová [République tchèque] ; A. Pavelková [République tchèque] ; J. Zvárová [République tchèque] ; J. Rovensk [République tchèque] ; A. Tuchy Ová [République tchèque]	Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics
000299 (2013)	J. J. Malemba ; J. M. Mbuyi Muamba ; J. Mukaya ; X. Bossuyt [Belgique] ; P. Verschueren [Belgique] ; R. Westhovens [Belgique]	Treatment of rheumatoid arthritis with methotrexate in Congolese patients
000322 (2010)	Ewa Wi Sik-Szewczyk [Pologne] ; Magdalena Romanowska [Pologne] ; Paweł Mielnik [Pologne] ; Hanna Chwali Ska-Sadowska [Pologne] ; Lidia B. Brydak [Pologne] ; Marzena Olesi Ska [Pologne] ; Jakub Z Bek [Pologne]	Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety
000325 (1995)	M. Kloppenburg ; B. A. C. Dijkmans ; F. C. Breedveld	Antimicrobial therapy for rheumatoid arthritis
000352 (2011)	Tobias Lahmer [Allemagne] ; Andreas Knopf [Allemagne] ; Ines Lanzl [Allemagne] ; Uwe Heemann [Allemagne] ; Klaus Thuermel [Allemagne]	Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study
000368 (2005)	J. Wenzel [Allemagne] ; S. Br Hler [Allemagne] ; R. Bauer [Allemagne] ; T. Bieber [Allemagne] ; T. Tüting [Allemagne]	Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients
000374 (2000)		Current Awareness
000408 (1997)	Carlos D. Rose [États-Unis] ; Bernhard H. Singsen [États-Unis] ; Andrew H. Eichenfield [États-Unis] ; Donald P. Goldsmith [États-Unis] ; Balu H. Athreya [États-Unis]	Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis
000688 (2005)	Rami Kotb [France] ; Caroline Pinganaud [France] ; Catherine Trichet [France] ; Olivier Lambotte [France] ; Marie Dreyfus [France] ; Jean-François Delfraissy [France] ; Gil Tchernia [France] ; Cécile Goujard [France]	Efficacy of mycophenolate mofetil in adult refractory auto‐immune cytopenias: a single center preliminary study
000692 (2015)	L. Cummins [Australie] ; V. S. Katikireddi [Australie] ; S. Shankaranarayana [Australie] ; K. Y. C. Su [Australie] ; E. Duggan [Australie] ; V. Videm [Australie, Norvège] ; H. Pahau [Australie] ; R. Thomas [Australie]	Safety and retention of combination triple disease‐modifying anti‐rheumatic drugs in new‐onset rheumatoid arthritis
000782 (1990)	Robert F. Willkens [États-Unis]	Resolve: Methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis
000830 (2009)		Current awareness: Pharmacoepidemiology and drug safety
000850 (2000)	Ronald D. Snyder [États-Unis]	Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical‐induced clastogenicity in Chinese hamster V79 cells
000881 (1995)	P. C. Rubin [Royaume-Uni]	Antimalarial drugs in pregnancy
000A00 (1994)	Yongyut Rojanasakul [États-Unis] ; Li Ying Wang [États-Unis] ; Carl J. Malanga [États-Unis] ; Joseph K. H. Ma [États-Unis] ; Jiahorng Liaw [Taïwan]	Targeted Gene Delivery to Alveolar Macrophages via Fc Receptor-Mediated Endocytosis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "safety" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "safety" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    safety
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021